Though heterogeneity is a key hallmark of cancer, and PSMA heterogeneous expression is well documented, the use of radionuclides helps to overcome the problem of heterogeneity by radiating both the cell to which it binds, and also the surrounding tumor microenvironment. The gene discussed is FOLH1; the disease is cancer.